Eli Lilly and Novo Nordisk May Soon Sell Weight Loss Drugs on the Planned TrumpRx. Could This Further Boost the Healthcare ...

Early results of Eli Lilly’s next generation of weight loss drugs appear to show promise, possibly leading to even faster ...

Researchers monitoring the brain activity of a patient with a severe binge-eating problem reported that Eli Lilly's GLP-1 ...

Facing increased competition in the weight loss market and intense pressure from President Donald Trump, Novo Nordisk ...

Signs of a weight loss price war appeared to worry investors early Monday, and Lilly and Novo stocks were down.

The deal, with Eli Lilly and Novo Nordisk, is expected to lower the price of obesity drugs to between $149 and $350 per month ...

The drugmaker said it would launch late-stage trials of the drug after participants lost as much as 20% of their body weight.

The race to develop the next generation of weight loss drugs has taken an interesting new turn. In recent research, Eli Lilly ...

(Reuters) -U.S. President Donald Trump on Thursday is expected to announce a deal with officials from Eli Lilly and Novo ...

Eli Lilly Strikes a Landmark Pricing Deal With the U.S. for Its Billion-Dollar Weight Loss Drugs. Here's What This Means for ...

David Ricks said drugs like Mounjaro and Zepbound are priced to reflect the costs involved, patent expiry, and the enormous ...

David Ricks' remarks followed a recent White House event where Trump announced his administration had reached a deal to lower ...